The dangers of prothrombin complex concentrate administration after heart surgery.
White
Ralph
R
Department of Cardiothoracic Surgery, Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK. ra1ph69@hotmail.com
Rushbrook
Jeremy
J
McGoldrick
Joe
J
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery; D001779:Blood Coagulation Factors / Q000009:adverse effects* / Q000627:therapeutic use; D002305:Cardiac Tamponade / Q000209:etiology* / Q000601:surgery; D006321:Heart; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008382:Marfan Syndrome / Q000150:complications; D010490:Pericardial Effusion / Q000150:complications*; D010492:Pericardiectomy; D010496:Pericardium; D011183:Postoperative Complications / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced* / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D014859:Warfarin